Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Multiple Sclerosis Ireland .
Filed returns
184
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2018 | Multiple Sclerosis Ireland | Health | Investment in neurology services (Matters involving public funds) | 20 | On lobbying.ie |
| Jan–Apr 2018 | Multiple Sclerosis Ireland | Health | Neurorehabilitation (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2018 | Multiple Sclerosis Ireland | Health | Access to new MS medications (Matters involving public funds) | 6 | On lobbying.ie |
| Jan–Apr 2018 | Multiple Sclerosis Ireland | Health | New MS medication ocrelizumab (Matters involving public funds) | 5 | On lobbying.ie |
| Sep–Dec 2017 | Multiple Sclerosis Ireland | Health | Meeting with Minister Jim Daly with other organisations involved in the Invest in Home Care campaign, to ask questions in relation to the next steps in the process of the recent consultation on home care. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2017 | Multiple Sclerosis Ireland | Health | Submissions made to the Department of Health consultations on establishing a statutory home care scheme, Personalised Budgets and draft Health Information Policy Framework (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2017 | Multiple Sclerosis Ireland | Health | Funding for MS Care Centre, 65 Bushy Park Road, Rathgar, Dublin 6 (Matters involving public funds) | 1 | On lobbying.ie |
| Sep–Dec 2017 | Multiple Sclerosis Ireland | Health | Letter to Minister Simon Harris regarding potential new pilot programme for reimbursement of new treatment for primary progressive MS, ocrelizumab. (Matters involving public funds) | 1 | On lobbying.ie |
| Sep–Dec 2017 | Multiple Sclerosis Ireland | Health | Implementation of the National Neurorehabilitation Strategy (Public policy or programme) | 67 | On lobbying.ie |
| May–Aug 2017 | Multiple Sclerosis Ireland | Health | Raised issue of inappropriate placement in nursing homes of people with MS (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2017 | Multiple Sclerosis Ireland | Health | Letter to Minister Simon Harris regarding the need to protect the titles of Physiotherapist and Physical Therapist and expressing concern about the upcoming Health and Social Care Professionals Amendment Bill (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2017 | Multiple Sclerosis Ireland | Health | Meeting regarding need to invest in home care services (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2017 | Multiple Sclerosis Ireland | Health | Meeting regarding availability of cannabis-based MS medication Sativex (Matters involving public funds) | 1 | On lobbying.ie |
| May–Aug 2017 | Multiple Sclerosis Ireland | Health | Need for investment in neurology services and development of implementation plan for National Clinical Programme for Neurology Model of Care (Matters involving public funds) | 30 | On lobbying.ie |
| Jan–Apr 2017 | Multiple Sclerosis Ireland | Health | Requesting publication of implementation plan for the National Clinical Programme for Neurology Model of Care, with budgets and timescales (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2017 | Multiple Sclerosis Ireland | Health | Requesting additional funding for the Multiple Sclerosis Care Centre - 12 bed respite care facility in Rathgar, Dublin (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2017 | Multiple Sclerosis Ireland | Health | Reimbursement of cannabis-based MS medication Sativex (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2016 | Multiple Sclerosis Ireland | Health | Protection of job titles of Physiotherapist and Physical Therapist (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2016 | Multiple Sclerosis Ireland | Health | Funding for neurology services (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2016 | Multiple Sclerosis Ireland | Health | Funding arrangements for MS medications Tysabri and Lemtrada (Matters involving public funds) | 1 | On lobbying.ie |
| Sep–Dec 2016 | Multiple Sclerosis Ireland | Health | Sativex - availability of licensed MS medication (Matters involving public funds) | 1 | On lobbying.ie |
| Sep–Dec 2016 | Multiple Sclerosis Ireland | Health | Neurorehabilitation - need to invest in and develop neurorehabilitation services (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2016 | Multiple Sclerosis Ireland | Health | Medical Cards (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2016 | Multiple Sclerosis Ireland | Health | Meetings regarding MS Ireland's general advocacy agenda. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2016 | Multiple Sclerosis Ireland | Health | Advocacy work regarding the MS medication Fampyra (Matters involving public funds) | 1 | On lobbying.ie |
| May–Aug 2016 | Multiple Sclerosis Ireland | Health | Advocacy work relating to the cannabis-based MS medication Sativex (Matters involving public funds) | 2 | On lobbying.ie |
| May–Aug 2016 | Multiple Sclerosis Ireland | Health | Neurorehabilitation (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2016 | Multiple Sclerosis Ireland | Health | Requesting meeting to discuss issues in the MS Ireland 2016 Advocacy Statement: http://www.ms-society.ie/uploads/File/Community/MS%20Ireland%20Advocacy%20Statement%2021012016.pdf (Matters involving public funds) | 2 | On lobbying.ie |
| Jan–Apr 2016 | Multiple Sclerosis Ireland | Health | Letter to Tony O'Brien regarding availability of MS medications that are currently only available via individual hospital budgets (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2016 | Multiple Sclerosis Ireland | Health | Question raised to the Director General of the HSE on the issue of underfunding for neurology services, via the National Patients' Forum (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2016 | Multiple Sclerosis Ireland | Health | Communication with the HSE regarding the systems for the reimbursement of the MS medication Fampyra. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2016 | Multiple Sclerosis Ireland | Health | Reimbursement of MS medication Sativex (Matters involving public funds) | 2 | On lobbying.ie |
| Sep–Dec 2015 | Multiple Sclerosis Ireland | Health | Implementation of the National Policy and Strategy for the Provision of Neuro-Rehabilitation Services 2011-2015 (Matters involving public funds) | 1 | On lobbying.ie |
| Sep–Dec 2015 | Multiple Sclerosis Ireland | Health | Implementation of the National Policy and Strategy for the Provision of Neuro-Rehabilitation Services 2011-2015 (Matters involving public funds) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 184 | 100.0% |